Stockscreener 앱 받기
3.66
4.44%
-0.17
시간 외 거래:
3.69
0.03
+0.82%
전일 마감가:
$3.83
열려 있는:
$3.9
하루 거래량:
516.95K
Relative Volume:
0.64
시가총액:
$241.98M
수익:
$69.23M
순이익/손실:
$-33.10M
주가수익비율:
-3.1017
EPS:
-1.18
순현금흐름:
$-39.26M
1주 성능:
+2.52%
1개월 성능:
+8.28%
6개월 성능:
+48.78%
1년 성능:
+92.63%
1일 변동 폭
$3.65
$3.92
1주일 범위
$3.525
$4.00
52주 변동 폭
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
STIM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.66 | 236.03M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
123.67 | 229.69B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.64 | 152.68B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
389.40 | 148.84B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.61 | 115.21B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.49 | 45.78B | 5.54B | 4.18B | 623.10M | 7.00 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
What drives Neuronetics Inc. stock priceExceptional return forecasts - Jammu Links News
Neuronetics Appoints New CFO as Company Targets Growth and Profitability Milestones - MSN
Neuronetics names Steven Pfanstiel as CFO - Medical Buyer
What makes Neuronetics Inc. stock price move sharplyTrade With Low Risk Exposure - Newser
Why Neuronetics Inc. stock attracts strong analyst attentionFree Stock Market Forecasting Tools - Newser
How Neuronetics Inc. stock performs during market volatilityTriple Digit Return Forecasts - Newser
Neuronetics, Inc. Announces Chief Financial Officer Changes - MarketScreener
Neuronetics Appoints Steven Pfanstiel As CFO; Reaffirms Q2, FY25 Guidance - Nasdaq
Neuronetics appoints new chief financial officer - MarketScreener
Neuronetics Appoints New CFO Amid Strategic Expansion - TipRanks
Neuronetics Appoints Steven Pfanstiel as CFO - MarketScreener
Neuronetics Appoints Steven Pfanstiel as New Chief Financial Officer, Reiterates Financial Guidance for 2025 - Nasdaq
Neuronetics Appoints New Chief Financial Officer - Yahoo Finance
Neuromodulation Devices Market is projected to reach USD 190.14 - openPR.com
Transcranial Magnetic Stimulator Market Set to Witness - openPR.com
Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting - Insider Monkey
Neuronetics, Inc.(NasdaqGM: STIM) added to Russell Small Cap Completeness Index - MarketScreener
Neuronetics, Inc.(NasdaqGM: STIM) added to Russell 2500 Index - MarketScreener
Neuronetics reports inducement grant - Medical Buyer
Neuronetics to Join Russell 3000 and Russell 2000 Indexes, Boosting Institutional Visibility - MSN
Insider Sellers Might Regret Selling Neuronetics Shares at a Lower Price Than Current Market Value - simplywall.st
Neuronetics to join Russell 3000 and Russell 2000 indexes - MSN
Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program - MarketScreener
Neuronetics (STIM) Showcases Innovations in Mental Health Care | - GuruFocus
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS - GuruFocus
Neuronetics (STIM) Showcases Innovations in Mental Health Care | STIM Stock News - GuruFocus
Neuronetics to Present New Research on TMS Therapy at 13th Annual Clinical TMS Society Meeting - Nasdaq
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program - The Manila Times
NeuroStar's Groundbreaking Study Shows How Its Depression Treatment Compares to Rival Brainsway: Key Findings - Stock Titan
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes - The Manila Times
Neuronetics set to join Russell indexes in June By Investing.com - Investing.com South Africa
Neuronetics set to join Russell indexes in June - Investing.com India
Neuronetics (STIM) to Join Russell 3000 and Russell 2000 Indexes - GuruFocus
Neuronetics Set To Join Russell 2000® And Russell 3000® Indexes - marketscreener.com
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes | STIM Stock News - GuruFocus
Neuronetics, Inc. to Join Russell 3000® and Russell 2000® Indexes Effective June 30, 2025 - Nasdaq
Major Milestone: Neuronetics Joins Russell 2000 and 3000 Indexes, Tapping Into $10.6T Benchmark Market - Stock Titan
Transcranial Magnetic Stimulator Market Future Business - openPR.com
Neuronetics reports annual meeting results By Investing.com - Investing.com Canada
Neuronetics reports annual meeting results - Investing.com Australia
Neuronetics Holds Annual Meeting, Elects Directors - TipRanks
Transcranial Magnetic Stimulators (TMS) Market to Set - openPR.com
Neuronetics' SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com UK
Neuronetics’ SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com Canada
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.28%
0.04%
자본화:
|
볼륨(24시간):